179.07
price up icon1.09%   1.935
after-market Handel nachbörslich: 179.08 0.005 +0.00%
loading
Schlusskurs vom Vortag:
$177.14
Offen:
$176.68
24-Stunden-Volumen:
184.65K
Relative Volume:
0.79
Marktkapitalisierung:
$3.51B
Einnahmen:
$152.42M
Nettoeinkommen (Verlust:
$45.24M
KGV:
71.34
EPS:
2.51
Netto-Cashflow:
$6.97M
1W Leistung:
+5.99%
1M Leistung:
+10.74%
6M Leistung:
+70.84%
1J Leistung:
+76.69%
1-Tages-Spanne:
Value
$176.68
$181.69
1-Wochen-Bereich:
Value
$163.45
$181.69
52-Wochen-Spanne:
Value
$93.58
$181.69

Ligand Pharmaceuticals Inc Stock (LGND) Company Profile

Name
Firmenname
Ligand Pharmaceuticals Inc
Name
Telefon
858-550-7500
Name
Adresse
3911 SORRENTO VALLEY BLVD, SAN DIEGO, CA
Name
Mitarbeiter
68
Name
Twitter
@Ligand_LGND
Name
Nächster Verdiensttermin
2025-02-18
Name
Neueste SEC-Einreichungen
Name
LGND's Discussions on Twitter

Vergleichen Sie LGND mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Biotechnology icon
LGND
Ligand Pharmaceuticals Inc
179.07 3.45B 152.42M 45.24M 6.97M 2.51
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
404.21 100.41B 11.39B 3.64B 3.50B 13.99
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
599.94 59.59B 14.21B 4.46B 3.56B 39.68
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
460.65 59.77B 2.46B -319.09M -52.09M -2.47
Biotechnology icon
ARGX
Argen X Se Adr
767.33 45.14B 3.06B 1.28B 447.35M 21.30
Biotechnology icon
ONC
Beone Medicines Ltd Adr
335.16 37.42B 3.81B -644.79M -669.77M -6.24

Ligand Pharmaceuticals Inc Stock (LGND) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2025-04-10 Eingeleitet Stifel Buy
2024-10-03 Eingeleitet Oppenheimer Outperform
2024-07-30 Eingeleitet RBC Capital Mkts Outperform
2021-04-14 Fortgesetzt Stephens Overweight
2021-02-04 Bestätigt H.C. Wainwright Buy
2020-10-06 Eingeleitet Barclays Overweight
2020-03-24 Herabstufung Argus Buy → Hold
2020-03-10 Eingeleitet Guggenheim Neutral
2020-02-06 Eingeleitet The Benchmark Company Buy
2019-09-19 Hochstufung Barclays Equal Weight → Overweight
2019-06-11 Eingeleitet Barclays Equal Weight
2019-05-03 Bestätigt H.C. Wainwright Buy
2019-03-06 Bestätigt H.C. Wainwright Buy
2018-10-29 Hochstufung ROTH Capital Neutral → Buy
2018-10-02 Bestätigt H.C. Wainwright Buy
2018-09-11 Bestätigt Argus Buy
2018-08-17 Eingeleitet Goldman Neutral
2018-08-08 Herabstufung ROTH Capital Buy → Neutral
2018-06-21 Eingeleitet Argus Buy
2017-12-27 Bestätigt H.C. Wainwright Buy
2017-09-05 Fortgesetzt H.C. Wainwright Buy
2016-10-05 Bestätigt H.C. Wainwright Buy
2016-08-05 Herabstufung Deutsche Bank Hold → Sell
2016-03-11 Eingeleitet Sidoti Buy
2016-03-03 Eingeleitet H.C. Wainwright Buy
Alle ansehen

Ligand Pharmaceuticals Inc Aktie (LGND) Neueste Nachrichten

pulisher
10:19 AM

Can Ligand Pharmaceuticals Incorporated stock deliver sustainable ROE2025 Technical Overview & Real-Time Buy Signal Alerts - newser.com

10:19 AM
pulisher
Sep 29, 2025

Ligand Pharmaceuticals IncorporatedEquity Right (LGNYZ) Price Target Increased by 410.53% to 0.05 - Nasdaq

Sep 29, 2025
pulisher
Sep 29, 2025

Ligand Pharmaceuticals stock hits 52-week high at $172.49 By Investing.com - Investing.com Canada

Sep 29, 2025
pulisher
Sep 28, 2025

What drives Ligand Pharmaceuticals Incorporated LGDN stock priceBollinger Bands Signals & Affordable Stock Market Tips - earlytimes.in

Sep 28, 2025
pulisher
Sep 27, 2025

What drives Ligand Pharmaceuticals Incorporated stock priceHead and Shoulders Patterns & Small Budget Capital Gains - Early Times

Sep 27, 2025
pulisher
Sep 27, 2025

What analysts say about Ligand Pharmaceuticals Incorporated LGDN stockDividend Reinvestment Plans & Small Investment Growth Tips - Early Times

Sep 27, 2025
pulisher
Sep 26, 2025

Ligand Pharmaceuticals Hits New 52-Week High of $170.78 - Markets Mojo

Sep 26, 2025
pulisher
Sep 26, 2025

Ligand Pharmaceuticals Hits New 52-Week High of $172.45 - Markets Mojo

Sep 26, 2025
pulisher
Sep 26, 2025

Congress Asset Management Co. Raises Stake in Ligand Pharmaceuticals Incorporated $LGND - MarketBeat

Sep 26, 2025
pulisher
Sep 25, 2025

Ligand Pharmaceuticals director Aryeh sells $1.7 million in shares By Investing.com - Investing.com Australia

Sep 25, 2025
pulisher
Sep 25, 2025

LGND: Ligand Pharmaceuticals Inks $11M Royalty Deal with Arecor - GuruFocus

Sep 25, 2025
pulisher
Sep 25, 2025

Arecor Therapeutics announces royalty financing agreement with Ligand to raise up to $11 mln - MarketScreener

Sep 25, 2025
pulisher
Sep 25, 2025

Arecor announces Co-development Agreement with US Insulin Pump Device Company for AT278 & Sale of Royalty Rights and Technology Access Fees for AT220 and AT292 - GlobeNewswire Inc.

Sep 25, 2025
pulisher
Sep 24, 2025

Ligand Pharmaceuticals director Aryeh sells $1.7 million in shares - Investing.com

Sep 24, 2025
pulisher
Sep 22, 2025

Ligand Pharmaceuticals (NASDAQ:LGND) Hits New 12-Month HighTime to Buy? - MarketBeat

Sep 22, 2025
pulisher
Sep 21, 2025

Contravisory Investment Management Inc. Acquires New Holdings in Ligand Pharmaceuticals Incorporated $LGND - MarketBeat

Sep 21, 2025
pulisher
Sep 21, 2025

Analysts Set Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) PT at $176.50 - MarketBeat

Sep 21, 2025
pulisher
Sep 20, 2025

Strs Ohio Takes Position in Ligand Pharmaceuticals Incorporated $LGND - MarketBeat

Sep 20, 2025
pulisher
Sep 19, 2025

What earnings revisions data tells us about Ligand Pharmaceuticals IncorporatedJuly 2025 Big Picture & Smart Swing Trading Alerts - newser.com

Sep 19, 2025
pulisher
Sep 19, 2025

Jobs Data: What is the dividend yield of Ligand Pharmaceuticals IncorporatedQuarterly Portfolio Report & Smart Allocation Stock Tips - khodrobank.com

Sep 19, 2025
pulisher
Sep 19, 2025

Is now a turning point for Ligand Pharmaceuticals IncorporatedTrade Analysis Summary & Weekly Market Pulse Updates - newser.com

Sep 19, 2025
pulisher
Sep 19, 2025

Will Ligand Pharmaceuticals Incorporated rebound enough to break even2025 AllTime Highs & Daily Chart Pattern Signals - newser.com

Sep 19, 2025
pulisher
Sep 19, 2025

Aug Setups: Is Ligand Pharmaceuticals Incorporated in a long term uptrendMarket Performance Summary & Capital Efficient Trading Techniques - خودرو بانک

Sep 19, 2025
pulisher
Sep 18, 2025

Rate Cut: Can Ligand Pharmaceuticals Incorporated outperform in the next rallyWatch List & Advanced Swing Trade Entry Alerts - خودرو بانک

Sep 18, 2025
pulisher
Sep 18, 2025

Earnings visualization tools for Ligand Pharmaceuticals Incorporated2025 Market Outlook & Long-Term Safe Return Strategies - newser.com

Sep 18, 2025
pulisher
Sep 18, 2025

Ligand Pharmaceuticals stock hits 52-week high at $169.72 By Investing.com - Investing.com Canada

Sep 18, 2025
pulisher
Sep 18, 2025

Rhumbline Advisers Sells 1,989 Shares of Ligand Pharmaceuticals Incorporated $LGND - MarketBeat

Sep 18, 2025
pulisher
Sep 18, 2025

Analyzing Ligand Pharmaceuticals (NASDAQ:LGND) and Provectus Biopharmaceuticals (OTCMKTS:PVCT) - Defense World

Sep 18, 2025
pulisher
Sep 18, 2025

Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) Given Average Rating of “Buy” by Analysts - Defense World

Sep 18, 2025
pulisher
Sep 18, 2025

Volume Recap: Is Ligand Pharmaceuticals Incorporated being accumulated by smart money2025 Trading Volume Trends & Advanced Swing Trade Entry Plans - خودرو بانک

Sep 18, 2025
pulisher
Sep 16, 2025

Aug Final Week: Will Ligand Pharmaceuticals Incorporated benefit from rising consumer demandPortfolio Risk Report & Weekly Setup with High ROI Potential - خودرو بانک

Sep 16, 2025
pulisher
Sep 16, 2025

Using data filters to optimize entry into Ligand Pharmaceuticals IncorporatedForecast Cut & Free Growth Oriented Trading Recommendations - newser.com

Sep 16, 2025
pulisher
Sep 16, 2025

Aug Rallies: Will Ligand Pharmaceuticals Incorporated outperform the market in YEARJuly 2025 Momentum & Stepwise Entry and Exit Trade Signals - خودرو بانک

Sep 16, 2025
pulisher
Sep 16, 2025

Aug Fed Impact: Will Ligand Pharmaceuticals Incorporated benefit from rising consumer demandJuly 2025 Rallies & Stock Portfolio Risk Management - خودرو بانک

Sep 16, 2025
pulisher
Sep 16, 2025

Ellsworth Advisors LLC Acquires Shares of 7,272 Ligand Pharmaceuticals Incorporated $LGND - MarketBeat

Sep 16, 2025
pulisher
Sep 16, 2025

Ligand Pharmaceuticals entered third amendment to credit agreementSEC filing - MarketScreener

Sep 16, 2025
pulisher
Sep 16, 2025

Ligand Pharmaceuticals Entered Third Amendment To Credit AgreementSEC Filing - TradingView

Sep 16, 2025
pulisher
Sep 16, 2025

Earnings Risk: Is Ligand Pharmaceuticals Incorporated a stock for growth or value investorsMarket Performance Summary & Daily Oversold Stock Bounce Ideas - خودرو بانک

Sep 16, 2025
pulisher
Sep 15, 2025

Pullback Watch: Will Ligand Pharmaceuticals Incorporated benefit from rising consumer demandQuarterly Earnings Summary & AI Driven Price Predictions - خودرو بانک

Sep 15, 2025
pulisher
Sep 15, 2025

Growth Value: What is Ligand Pharmaceuticals Incorporated’s TAM (Total Addressable Market)Entry Point & Consistent Income Trade Recommendations - خودرو بانک

Sep 15, 2025
pulisher
Sep 15, 2025

Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) Sees Significant Increase in Short Interest - MarketBeat

Sep 15, 2025
pulisher
Sep 15, 2025

Market Moves: What is the next catalyst for Ligand Pharmaceuticals IncorporatedJuly 2025 Breakouts & Daily Profit Focused Stock Screening - خودرو بانک

Sep 15, 2025
pulisher
Sep 15, 2025

What’s the recovery path for long term holders of Ligand Pharmaceuticals IncorporatedJuly 2025 Market Mood & Precise Buy Zone Tips - newser.com

Sep 15, 2025
pulisher
Sep 14, 2025

Real time social sentiment graph for Ligand Pharmaceuticals IncorporatedJuly 2025 Price Swings & Free Expert Approved Momentum Trade Ideas - newser.com

Sep 14, 2025
pulisher
Sep 14, 2025

Ligand Pharmaceuticals Incorporated $LGND Shares Sold by Baird Financial Group Inc. - MarketBeat

Sep 14, 2025
pulisher
Sep 13, 2025

Visual analytics tools that track Ligand Pharmaceuticals Incorporated performanceTrade Exit Summary & Verified Short-Term Plans - newser.com

Sep 13, 2025
pulisher
Sep 12, 2025

Jacobs Levy Equity Management Inc. Makes New $16.53 Million Investment in Ligand Pharmaceuticals Incorporated $LGND - MarketBeat

Sep 12, 2025

Finanzdaten der Ligand Pharmaceuticals Inc-Aktie (LGND)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
$36.32
price up icon 2.95%
$86.70
price up icon 2.23%
$31.77
price up icon 3.59%
$102.21
price up icon 3.64%
$147.28
price up icon 2.27%
biotechnology ONC
$335.16
price down icon 1.63%
Kapitalisierung:     |  Volumen (24h):